Matisse Capital - BIOHAVEN PHARMACTL HLDG CO L ownership

Back to all holdings Add to watchlist

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 103 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
Matisse Capital ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q4 2017$270,000
-27.8%
10,0000.0%0.12%
-30.9%
Q3 2017$374,000
+49.6%
10,0000.0%0.18%
+40.2%
Q2 2017$250,000–10,000–0.13%–
 Download
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 450,422$6,251,85714.11%
Liontrust Investment Partners LLP 134,659$7,478,9610.13%
Birchview Capital, LP 7,365$1020.07%
FNY Investment Advisers, LLC 250$30.00%
FNY Investment Advisers, LLC 18$00.00%
FNY Investment Advisers, LLC 56$00.00%
McElhenny Sheffield Capital Management, LLC 31$4300.00%
Blue Trust, Inc. 65$100.00%
IFP Advisors, Inc 1$10.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders